National Cancer Centre Singapore

National Cancer Centre Singapore is number 1159 in the 311 Titans Index of the world's largest companies, with reported revenue of about $5.7bn in . It is headquartered in Singapore. In short: Hospital in Singapore. 311 Future Exposure: medium (43/100), driven by technology change in healthcare (76/100), led by 5G, Artificial Narrow Intelligence, Biometric Sensors.

Part of the 311 Titans Index (311institute.com). Last updated 5 October 2026.

311 Future Exposure: Medium

Score 43 out of 100: technology 76/100 and trends 10/100. What drives it:

• Technology change in healthcare (76/100), led by 5G, Artificial Narrow Intelligence, Biometric Sensors

Technology exposure uses the 311 Starburst: how strongly each emerging technology affects this industry, weighted by how soon it reaches widespread use. Trend exposure covers tariffs and export controls, international sanctions. Evidence on company-specific trends is being added. Explore the Starburst.

Other Titans in Singapore

• Trafigura (#21)
• Sea Limited (#359)
• Seagate Technology Holdings plc (#800)
• Trip.com Group Limited (#837)
• Grab Holdings Ltd (#1633)
• JOYY (#2127)
• VinFast Auto Ltd (#2300)

Related

• Singapore: economy and key statistics
• The 311 Titans Index
• All 311 Indexes

Questions and answers

Source: Wikidata (company-reported figure).

© 311 Institute 2026. Facts from official filings, Wikidata (CC0) and the sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.